Literature DB >> 31424440

In Vitro Assay to Study Tumor-macrophage Interaction.

Zhenyi An1, William A Weiss2.   

Abstract

Tumor associated macrophages (TAMs) account for a large percentage of cells in the tumor mass for different types of cancers. Glioblastoma (GBM), a malignant brain tumor with no cure, has up to a half the tumor mass TAMs. TAMs can be pro-tumoral or anti-tumoral, depending on the activation of specific genes in the cells. Genetic mutations in the tumors, through regulating cytokine expression, can affect recruitment of TAMs to the tumor microenvironment. Here, we describe a quantitative cell-based assay to assess macrophage recruitment by the conditioned medium from the tumor cells. This assay uses the human macrophage cell line MV-4-11 to study macrophage attraction by the conditioned medium from glioblastoma, allowing for high reproducibility and low variability. Data generated with this assay can contribute to a better understanding of the interaction between the tumor and the tumor microenvironment. Similar assay can be used to assess interaction between the tumor cells and other immune cells, including T cells and natural killer (NK) cells.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31424440      PMCID: PMC7401762          DOI: 10.3791/59907

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  14 in total

1.  EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma.

Authors:  Zhenyi An; Christiane B Knobbe-Thomsen; Xiaohua Wan; Qi Wen Fan; Guido Reifenberger; William A Weiss
Journal:  Cancer Res       Date:  2018-11-06       Impact factor: 12.701

2.  Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype.

Authors:  Simone Borgoni; Andrea Iannello; Santina Cutrupi; Paola Allavena; Maurizio D'Incalci; Francesco Novelli; Paola Cappello
Journal:  Oncoimmunology       Date:  2017-11-13       Impact factor: 8.110

Review 3.  The chemokine system in innate immunity.

Authors:  Caroline L Sokol; Andrew D Luster
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-29       Impact factor: 10.005

Review 4.  Targeting Tumor-Associated Macrophages in Cancer.

Authors:  Paulina Pathria; Tiani L Louis; Judith A Varner
Journal:  Trends Immunol       Date:  2019-03-17       Impact factor: 16.687

Review 5.  Structural Analysis of Chemokine Receptor-Ligand Interactions.

Authors:  Marta Arimont; Shan-Liang Sun; Rob Leurs; Martine Smit; Iwan J P de Esch; Chris de Graaf
Journal:  J Med Chem       Date:  2017-03-10       Impact factor: 7.446

Review 6.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

Review 7.  Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease.

Authors:  Mark D Turner; Belinda Nedjai; Tara Hurst; Daniel J Pennington
Journal:  Biochim Biophys Acta       Date:  2014-06-02

Review 8.  Tumour-associated macrophages as treatment targets in oncology.

Authors:  Alberto Mantovani; Federica Marchesi; Alberto Malesci; Luigi Laghi; Paola Allavena
Journal:  Nat Rev Clin Oncol       Date:  2017-01-24       Impact factor: 66.675

Review 9.  Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis.

Authors:  Vladimir Riabov; Alexandru Gudima; Nan Wang; Amanda Mickley; Alexander Orekhov; Julia Kzhyshkowska
Journal:  Front Physiol       Date:  2014-03-05       Impact factor: 4.566

Review 10.  Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers.

Authors:  Nicolas Jacquelot; Connie P M Duong; Gabrielle T Belz; Laurence Zitvogel
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.